Consensus on the Cosmetic Use of a Novel Botulinum Neurotoxin Type A Product (NEWLUX®) for Facial Expression Muscles: 2024 Guidelines and Discussions by Korean Experts
This updated consensus guideline provides practical recommendations from Korean experts on the use of the novel BoNTA product for facial expression muscles. The guidelines will ensure safe and effective treatments while reflecting the latest advancements in the field.
Authors
- Y.W. Lee
- Wook Oh
- Hyoung Moon Kim (ORCID: https://orcid.org/0000-0001-9068-5813)
- Hong-Ki Lee (ORCID: https://orcid.org/0000-0003-3670-386X)
- H.A. Kim
- Wu‐Chul Song (ORCID: https://orcid.org/0000-0001-9678-1830)
- Nark‐Kyoung Rho (ORCID: https://orcid.org/0000-0003-0341-3460)
- Moon Seop Choi (ORCID: https://orcid.org/0000-0002-2307-5115)
- Gee Young Bae
- Woon-Kyong Chung
Institutions
- Dr Youth Clinic (KR)
Publication Details
- Journal
- Toxins
- Published
- 2025-01-29
- DOI
- https://doi.org/10.3390/toxins17020061
- Citations
- 1
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Yonsei University
- Yonsei University College of Dentistry